Upload prescription

Upload Proscription (Max 2MB)
Home/Package/Drugs Panel

Drugs Panel

Drugs of abuse encompass a wide range of substances that pose significant health and legal risks due to their potential for addiction and harmful effects. Toxicology screening is a critical tool used to detect these substances in biological samples, aiding in medical, forensic, and workplace contexts. Commonly misused drugs include stimulants, depressants, hallucinogens, and opioids, each with distinct physiological impacts. Screening identifies recent use, guiding treatment or legal actions. Advanced methods, like those employed by Leo Labs, enhance detection accuracy, ensuring reliable results. Such screenings are vital for addressing substance abuse, promoting public safety, and supporting rehabilitation efforts.

4,000.00

Drugs Panel

Tests

Amphetamine

Barbiturates

Benzodiazepine

Cocaine

Methamphetamine

Morphine

Propoxyphene

TCA

Ecstasy MDMA

Methadone

Cannabinoid/THC (Tetrahydrocannabinols)

PCP- Phencyclidine (Urine)

Frequently Asked Questions

A Drugs Panel test screens for commonly abused substances, including opioids, amphetamines, cocaine, marijuana (THC), benzodiazepines, barbiturates, and synthetic drugs. This toxicology screen helps detect recent drug exposure, substance misuse, and patterns of addiction, supporting medical evaluation, workplace compliance, and rehabilitation programs.
Yes, a comprehensive Drugs Panel detects illegal substances and prescription drug misuse, including opioid painkillers, benzodiazepines, and ADHD medications. Toxicology screening helps identify non-medical use, overuse, or diversion, offering doctors and rehabilitation centers accurate insights into a person’s drug-related risks and behavioral patterns.
Drug detection windows vary by substance, metabolism, dosage, and test type. Urine usually detects drugs for 1–7 days, blood for hours to 48 hours, saliva for 1–3 days, and hair for up to 90 days, making comprehensive toxicology screening essential for accurate assessment.
A Drugs Panel may use urine, blood, saliva, or hair samples depending on the required detection window. Urine tests are most common, blood offers real-time intoxication data, saliva detects recent use, and hair provides long-term patterns, supporting medical, workplace, and forensic needs.
Yes, urine drug testing typically detects more substances for longer periods than blood tests. Urine captures metabolized drug byproducts, offering a broader, more sensitive detection window, while blood tests mainly reflect current intoxication or very recent use, making urine ideal for routine toxicology screening.
Rehabilitation programs often perform drug testing weekly or biweekly to monitor sobriety, verify compliance, and guide treatment decisions. High-risk patients may need more frequent screening. Regular toxicology testing helps track progress, prevent relapse, and support structured recovery with objective, medically reliable data.
Fasting or dehydration can slightly concentrate urine, potentially increasing metabolite levels, but modern toxicology screening adjusts for sample dilution through creatinine and specific gravity checks. Hydration changes rarely cause false positives, ensuring accurate detection of substances within Drugs Panel testing.
Pure CBD does not trigger a positive drug test, but many CBD oils contain trace THC, which may appear in toxicology screening. Low-quality or unregulated products increase this risk, so individuals subject to drug panels should choose verified THC-free CBD formulations.